Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013

University Hospital, Angers · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
small-cell-lung-cancer
The purpose of this study was to determine prospectively in all patients with SCLC in second line therapy that progression-free survival with the expected reintroduction of platinum / etoposide is greater progression-free survival in the standard arm (topotecan ) in patients who have relapsed at least three months after initial chemotherapy with platinum-etoposide
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1044627
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive